drugset / Trial / NCT07111325

Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus

NCT07111325 ↗

Phase 1/2 Recruiting 24 enrolled Shanghai 6th People's Hospital
Non-randomizedParallel-groupSingle-blindTreatment

Summary

Evaluate the safety and preliminary efficacy of human induced pluripotent stem cell-derived extracellular vesicle (iEV) injection in the treatment of lateral epicondylitis of the humerus.

Timeline

Start
2023-07-01
Primary completion
2025-12-01
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator PRP Other / unclassified — —
Subject iEV Other / unclassified 1e+09 unknown —
Subject iEV Other / unclassified 1e+10 unknown —

Indications